Attached files
file | filename |
---|---|
10-Q - FORM 10-Q - Protalix BioTherapeutics, Inc. | y04168e10vq.htm |
EX-31.1 - EX-31.1 - Protalix BioTherapeutics, Inc. | y04168exv31w1.htm |
EX-10.2 - EX-10.2 - Protalix BioTherapeutics, Inc. | y04168exv10w2.htm |
EX-32.1 - EX-32.1 - Protalix BioTherapeutics, Inc. | y04168exv32w1.htm |
EX-31.2 - EX-31.2 - Protalix BioTherapeutics, Inc. | y04168exv31w2.htm |
EXHIBIT 32.2
PROTALIX BIOTHERAPEUTICS, INC.
CERTIFICATION
In connection with the quarterly report of Protalix BioTherapeutics, Inc. (the Company) on Form
10-Q for the period ended September 30, 2010 as filed with the Securities and Exchange Commission
(the Report), I, Yossi Maimon, Vice President and Chief Financial Officer of the Company, hereby
certify as of the date hereof, solely for the purposes of Title 18, Chapter 63, Section 1350 of the
United States Code, that to the best of my knowledge:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable,
of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company at the dates and for the periods
indicated.
This Certification has not been, and shall not be deemed, filed with the Securities and Exchange
Commission.
Date: November 8, 2010 |
||
/s/ Yossi Maimon
|
||
Vice President and Chief Financial Officer |